• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Patterns of local relapse following tumor-targeted dose escalation for localized prostate cancer

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Padayachee, J.
    Sanmamed, N.
    Lee, J.
    Liu, Z.
    Berlin, A.
    Craig, T.
    Lao, B.
    Rink, A.
    Bayley, A.
    Catton, C.
    Sundaramurthy, A.
    Foltz, W.
    McPartlin, Andrew J
    Ghai, S.
    Atenafu, E.
    Gospodarowicz, M.
    Warde, P.
    Helou, J.
    Raman, S.
    Menard, C.
    Chung, P.
    Show allShow less
    Affiliation
    Princess Margaret Cancer Centre, Radiation Medicine Program, Toronto, Canada
    Issue Date
    2021
    
    Metadata
    Show full item record
    Abstract
    Purpose or Objective Tumor-targeted dose escalation may improve local control rates in patients with prostate cancer, leading to improved biochemical failure-free survival (bFFS). We report outcomes of dose escalation using a strategy of simultaneous integrated boost or HDR brachytherapy boost. Materials and Methods Eighty patients with localized prostate cancer with GTV identified on multiparametric MRI (mpMRI) were enrolled in this phase 2 non-randomized trial (2012-2016). Patients with GTV >5mm and less than 33% of total prostate volume were eligible. All patients received whole gland prostate VMAT, 76 Gy in 38 fractions. Choice of GTV dose escalation was by physician and/or patient choice and delivered by integrated boost VMAT (IB-VMAT) of 95 Gy in 38 fractions (n=40); or MRI-guided HDR boost of 10 Gy in 1 fraction (n=40). The primary endpoint was 3-year local control rates determined by MRI-guided biopsy and/or MRI alone. Toxicity data was collected using CTCAE v.4.0. Risk group categorization was comparable between the arms; 5% low-, 75% intermediate-, and 20% high-risk. Three patients received 6-months of concurrent/adjuvant ADT. Results Median (IQR) follow-up was 55.2 months (48.1-71.4). The overall 5-year bFFS was 92% (95% CI, 85-99). Late G2 GU toxicity was 22.5% and 27.5% in IB-VMAT and HDR boost arms, respectively. Late G2 GI toxicity was 5% in each arm. Two G3 (1 GI, 1 GU) toxicities were seen in IB-VMAT. Local control data was available for 66 patients who agreed to the 3-year post-treatment biopsy (20) or MRI alone (46); 32 in IB-VMAT and 34 in HDR boost. Local control within the boost volume was achieved in 61 patients. One patient in the IB-VMAT arm had persistent disease on biopsy, and subsequently met criteria for biochemical relapse (BCR). At last follow-up of the 66 patients, 4 developed BCR with evidence of intraprostatic relapse outside the boost volume; 1 treated with IB-VMAT and 3 with HDR boost. The spatial distribution of these relative to the boost volume were: ipsilateral lobe (IB-VMAT), marginal/contralateral/bilateral (HDR boost). These relapses appeared to correlate to sites of known microscopic disease at original diagnosis. Conclusion Dose escalation to mpMRI-defined GTV provided high rates of local and biochemical control with a favorable late toxicity profile. The majority of local treatment failures developed beyond the tumor-targeted volume, suggesting that other treatment intensification strategies may be required to further improve outcomes.
    Citation
    Padayachee J, Sanmamed N, Lee J, Liu Z, Berlin A, Craig T, et al. Patterns of local relapse following tumor-targeted dose escalation for localized prostate cancer. Radiotherapy and Oncology. 2021;161:S1109-S.
    Journal
    Radiotherapy and Oncology
    URI
    http://hdl.handle.net/10541/624888
    Type
    Meetings and Proceedings
    Language
    en
    Collections
    All Christie Publications

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.